Hematology Market Expected to Reach US$ 4537.5 Million by 2022

Market Overview:

The global Hematology Market is estimated to be valued at US$ 4537.5 Million In 2019 and is expected to exhibit a CAGR of 7.80% over the forecast period 2019-2027, as highlighted in a new report published by Coherent Market Insights. Hematology products play a crucial role in the diagnosis, treatment, and management of blood-related diseases and disorders. These products include various instruments, reagents, and consumables used in laboratories and healthcare settings for the analysis and study of blood and blood-forming organs. The rising prevalence of blood disorders and the increasing demand for accurate and efficient diagnostic techniques are driving the growth of the hematology market. Additionally, advancements in technology and the emergence of automated hematology analyzers are further fueling market growth.

Market Key Trends:

One key trend in the hematology market is the increasing adoption of point-of-care testing (POCT) devices. POCT devices offer fast and convenient testing at the patient's bedside or in a non-laboratory setting. These devices provide immediate results, eliminate the need for sample transportation, and allow healthcare professionals to make prompt decisions regarding patient care. The demand for POCT devices is growing due to their ability to provide real-time test results, particularly in emergency situations or in remote areas where access to laboratory facilities is limited. Moreover, the use of POCT devices reduces the turnaround time for test results, improving patient outcomes and reducing overall healthcare costs. The market for POCT devices in hematology is expected to witness significant growth during the forecast period as healthcare providers increasingly recognize the advantages and convenience offered by these devices.
Segment Analysis:

The hematology market can be segmented based on product type, end-user, and region. Based on product type, the market can be divided into instruments, reagents, and consumables. The instruments segment dominates the market and is expected to continue its dominance over the forecast period. This can be attributed to the increasing demand for automated hematology instruments that provide accurate and efficient results. Moreover, the advancements in technology and the integration of advanced features in these instruments are further driving the growth of this segment.

In terms of end-user, the Hematology Market can be segmented into hospitals, diagnostic laboratories, research institutions, and others. Among these, the hospitals segment holds the largest market share due to the high patient footfall and the growing prevalence of hematological disorders. Additionally, the increasing investments in healthcare infrastructure and the rising demand for point-of-care testing in hospitals are contributing to the dominance of this segment.

Key Takeaways:

The global hematology market is expected to witness high growth, exhibiting a CAGR of 7.80% over the forecast period. This growth can be attributed to various factors, including the increasing prevalence of hematological disorders, technological advancements in hematology instruments, and the growing demand for personalized medicine.

From a regional perspective, North America is the fastest-growing and dominating region in the hematology market. This can be attributed to the presence of well-established healthcare infrastructure, high healthcare expenditure, and the availability of advanced diagnostic technologies in the region. Moreover, the increasing geriatric population and the rising incidence of blood-related disorders are further driving the market growth in this region.

Key players operating in the hematology market include Abbott Laboratories, Sysmex Co., Beckman Coulter, Horiba, Ltd., Boule Diagnostics AB, Mindray Medical International Limited, Siemens Healthcare, Roche Diagnostics, Bio-Rad Laboratories, Sigma Aldrich Co., and Nihon Kohden Corporation. These key players focus on strategic collaborations, mergers and acquisitions, and product innovations to strengthen their market position. They also invest in research and development activities to launch technologically advanced products, thereby gaining a competitive edge in the market.

Read More : https://www.rapidwebwire.com/hematology-market-growing-prevalence-of-blood-disorders-driving-market-growth/